Literature DB >> 22210833

Omecamtiv mecarbil: a promising new drug in systolic heart failure.

Matthijs F L Meijs, Folkert W Asselbergs, Pieter A Doevendans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22210833     DOI： 10.1093/eurjhf/hfr178

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  6 in total

1.  The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.

Authors:  L Nagy; Á Kovács; B Bódi; E T Pásztor; G Á Fülöp; A Tóth; I Édes; Z Papp
Journal:  Br J Pharmacol       Date:  2015-08-04       Impact factor: 8.739

Review 2.  Novel drug targets in clinical development for heart failure.

Authors:  Melvin George; Muthukumar Rajaram; Elangovan Shanmugam; Thangavel Mahalingam VijayaKumar
Journal:  Eur J Clin Pharmacol       Date:  2014-04-09       Impact factor: 2.953

Review 3.  Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy.

Authors:  Mark T Waddingham; Amanda J Edgley; Hirotsugu Tsuchimochi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  World J Diabetes       Date:  2015-07-10

Review 4.  Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus.

Authors:  László Nagy; Piero Pollesello; Zoltán Papp
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

Review 5.  Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice.

Authors:  Vasiliki Bistola; Angelos Arfaras-Melainis; Eftihia Polyzogopoulou; Ignatios Ikonomidis; John Parissis
Journal:  Card Fail Rev       Date:  2019-11-04

6.  2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure.

Authors:  Farid Moussavi-Harami; Maria V Razumova; Alice W Racca; Yuanhua Cheng; April Stempien-Otero; Michael Regnier
Journal:  J Mol Cell Cardiol       Date:  2014-12-10       Impact factor: 5.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.